Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)

NCT00425256 is registered in ClinicalTrials.gov with Palatin Technologies, Inc as lead sponsor.

NCT NCT00425256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00425256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)
Lead sponsor
Palatin Technologies, Inc
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2006
Completion date
May 31, 2007
Enrollment
Not reported
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

sexual arousal disorder